ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Friday, 13 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Q-Line Biotech Acquisition Worth ₹26.64 Cr

Q-Line Biotech agreed to buy 70% of unlisted Heidelco Medicore for Rs.26.64 Crore in cash. The target becomes a subsidiary through this related-party acquisition.

Key figures
Value₹26.64 Cr
Execution periodMaximum three months from signing of SPAs, extendable by mutual agreement
Source

NSE filing, NSE: QLINE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Q-Line Biotech Ltd: key numbers

Share price
₹553.85
Market cap
₹1,292 Cr
Revenue (annual)
₹341.7 Cr
Net profit (annual)
₹55.72 Cr
P/E (TTM)
23.2×Sector 54.7×
Promoter holding
67.51%
FII holding
0.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Q-Line Biotech Ltd

All →

Other acquisition announcements

All →